Table 2.
Cost per daya (US$) | Control group | Treatment group | |||||||
---|---|---|---|---|---|---|---|---|---|
Total days | Total cost (US$) | Subjects | Cost per subject (US$) | Total days | Total cost (US$) | Subjects | Cost per subject (US$) | ||
CHF | 2232 | 517 | 1154,129 | 78 | 14,797 | 454 | 1,013,490 | 79 | 12,829 |
AMI | 4318 | 98 | 423,163 | 25 | 16,927 | 138 | 595,882 | 30 | 19,863 |
Pneumonia | 1953 | 621 | 1,213,000 | 100 | 12,130 | 669 | 1,306,759 | 95 | 13,755 |
COPD | 1868 | 634 | 1,184,345 | 106 | 11,173 | 620 | 1,158,193 | 109 | 10,626 |
Total | 1870 | 3,974,638 | 309 | 12,863 | 1881 | 4,074,324 | 313 | 13,107 |
CHF congestive heart failure, AMI acute myocardial infarction, COPD chronic obstructive pulmonary disease
aCost estimates come from the 2012 Healthcare Cost and Utilization Project (HCUP) database [16]
bDifferences between the control and treatment groups did not achieve statistical significance (p < 0.05)